{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:01:32Z","timestamp":1792119692345,"version":"4.4.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamadermatol.2020.1729","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T11:01:58Z","timestamp":1596020518000},"page":"1004","source":"Crossref","is-referenced-by-count":87,"title":["Prognostic Gene Expression Profiling in Cutaneous Melanoma"],"prefix":"10.1001","volume":"156","author":[{"given":"Douglas","family":"Grossman","sequence":"first","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, Utah"},{"name":"Department of Dermatology, University of Utah, Salt Lake City"},{"name":"Department of Oncological Sciences, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwanneka","family":"Okwundu","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Othus","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Coit","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca I.","family":"Hartman","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Dermatology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sancy A.","family":"Leachman","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Knight Cancer Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Berry","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Knight Cancer Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Korde","sequence":"additional","affiliation":[{"name":"Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Data Sciences, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menashe","family":"Bar-Eli","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Berwick","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Internal Medicine, University of New Mexico Cancer Center, University of New Mexico, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawnya","family":"Bowles","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth I.","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Internal Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Burton","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Curiel-Lewandrowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology and University of Arizona Cancer Center, University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Curtis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Daud","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco"},{"name":"Department of Hematology\/Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekker C.","family":"Deacon","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Ferris","sequence":"additional","affiliation":[{"name":"Department of Dermatology and University of Pittsburgh Clinical and Translational Science Institute, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Gershenwald","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F.","family":"Grossmann","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, Utah"},{"name":"Department of Medicine, Division of Oncology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Hu-Lieskovan","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, Utah"},{"name":"Department of Medicine, Division of Oncology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hyngstrom","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, Utah"},{"name":"Department of Surgery, Division of Surgical Oncology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Jeter","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and The Ohio State University Comprehensive Cancer Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Judson-Torres","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, Utah"},{"name":"Department of Dermatology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari L.","family":"Kendra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and The Ohio State University Comprehensive Cancer Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tufts Medical Center, Boston, Massachusetts"},{"name":"Partners Healthcare, Newton Wellesley Dermatology Associates, Wellesley, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Lawson","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Leming","sequence":"additional","affiliation":[{"name":"Cincinnati Cancer Advisors, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia"},{"name":"Charles Perkins Centre, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq A.","family":"Marghoob","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Mehnert","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Robert Wood Johnson University Hospital, New Brunswick, New Jersey"},{"name":"Rutgers Cancer Institute of New Jersey, New Brunswick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Polsky","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ronald O. Perelman Department of Dermatology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon K.","family":"Sondak","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida"},{"name":"Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Stark","sequence":"additional","affiliation":[{"name":"The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ronald O. Perelman Department of Dermatology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, Washington"},{"name":"Department of Oncology, University of Washington, Seattle"},{"name":"Seattle Cancer Care Alliance, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj S.","family":"Venna","sequence":"additional","affiliation":[{"name":"Inova Schar Cancer Institute, Department of Medicine, Virginia Commonwealth University, Fairfax"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Wei","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco"},{"name":"Department of Dermatology, University of California, San Francisco"},{"name":"Dermatology Service, Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Swetter","sequence":"additional","affiliation":[{"name":"Stanford University Medical Center and Cancer Institute, Stanford, California"},{"name":"Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"dcs200001r1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma.","volume":"80","author":"Swetter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"dcs200001r6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaad.2019.08.022","article-title":"Use of new molecular tests for melanoma by pigmented-lesion experts.","volume":"82","author":"Varedi","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"dcs200001r7","doi-asserted-by":"publisher","first-page":"MMT32","DOI":"10.2217\/mmt-2019-0016","article-title":"Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice.","volume":"6","author":"Grossman","year":"2019","journal-title":"Melanoma Manag"},{"issue":"11","key":"dcs200001r8","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2217\/fon-2018-0912","article-title":"Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling.","volume":"15","author":"Vetto","year":"2019","journal-title":"Future Oncol"},{"issue":"5","key":"dcs200001r9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/jid.2012.3","article-title":"Survival is not the only valuable end point in melanoma screening.","volume":"132","author":"Curiel-Lewandrowski","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"dcs200001r10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/jamadermatol.2014.2694","article-title":"Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi\/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.","volume":"151","author":"Kim","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"7","key":"dcs200001r11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome.","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"dcs200001r12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00432-012-1322-z","article-title":"A nine-gene signature predicting clinical outcome in cutaneous melanoma.","volume":"139","author":"Brunner","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"issue":"23","key":"dcs200001r13","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1200\/JCO.2014.60.7002","article-title":"Tumor cell adhesion as a risk factor for sentinel lymph node metastasis in primary cutaneous melanoma.","volume":"33","author":"Meves","year":"2015","journal-title":"J Clin Oncol"},{"key":"dcs200001r14","doi-asserted-by":"publisher","first-page":"v540","DOI":"10.1093\/annonc\/mdz255.014","article-title":"Validation of a clinicopathological and gene expression profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma","volume":"30","author":"Mulder","year":"2019","journal-title":"Ann Oncol"},{"issue":"13","key":"dcs200001r15","doi-asserted-by":"publisher","first-page":"11683","DOI":"10.18632\/oncotarget.v6i13","article-title":"Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.","volume":"6","author":"Nsengimana","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"dcs200001r16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"dcs200001r17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"dcs200001r18","article-title":"Melanoma prognosis\u2014accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.","author":"Bajaj","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"dcs200001r19","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond.","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"dcs200001r21","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma.","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"dcs200001r22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"issue":"27","key":"dcs200001r23","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"issue":"23","key":"dcs200001r24","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","article-title":"Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.","volume":"24","author":"Paik","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"dcs200001r25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (?1?mm) than from thick melanomas (>4?mm) in Queensland, Australia.","volume":"135","author":"Whiteman","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"dcs200001r26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12885-018-4016-3","article-title":"Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.","volume":"18","author":"Zager","year":"2018","journal-title":"BMC Cancer"},{"issue":"12","key":"dcs200001r27","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1097\/DSS.0000000000001588","article-title":"Estimation of prognosis in invasive cutaneous melanoma: an independent study of the accuracy of a gene expression profile test.","volume":"44","author":"Greenhaw","year":"2018","journal-title":"Dermatol Surg"},{"issue":"1","key":"dcs200001r28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-017-0520-1","article-title":"Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.","volume":"10","author":"Hsueh","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"15","key":"dcs200001r29","article-title":"Three-year survival outcomes in a prospective cohort evaluating a prognostic 31-gene expression profile (31-GEP) test for cutaneous melanoma (CM)","volume":"37","author":"Hsueh","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"dcs200001r30","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1002\/cam4.2019.8.issue-5","article-title":"Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma.","volume":"8","author":"Keller","year":"2019","journal-title":"Cancer Med"},{"issue":"5","key":"dcs200001r31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/jdv.2019.33.issue-5","article-title":"Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. a prospective multicentre cohort study.","volume":"33","author":"Podlipnik","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"dcs200001r32","article-title":"Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.","author":"Greenhaw","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"dcs200001r33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00000658-199008000-00010","article-title":"Late recurrence of malignant melanoma. analysis of 168 patients.","volume":"212","author":"Crowley","year":"1990","journal-title":"Ann Surg"},{"issue":"4","key":"dcs200001r34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.sla.0000090446.63327.40","article-title":"Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.","volume":"238","author":"Kalady","year":"2003","journal-title":"Ann Surg"},{"issue":"4","key":"dcs200001r35","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1245\/s10434-017-6325-1","article-title":"Long-term survival of patients with thin (T1) cutaneous melanomas: a Breslow thickness cut point of 0.8 mm separates higher-risk and lower-risk tumors.","volume":"25","author":"Lo","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"dcs200001r36","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/j.jaad.2018.11.063","article-title":"Use of a prognostic gene expression profile test for T1 cutaneous melanoma: will it help or harm patients?","volume":"80","author":"Marchetti","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"dcs200001r37","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.e21037","article-title":"Gene-signature based prediction of relapse-free survival in melanoma patients with known sentinel lymph node status.","volume":"35","author":"Gambichler","year":"2017","journal-title":"J Clin Oncol"},{"key":"dcs200001r38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2019.10.027","article-title":"Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma.","volume":"125","author":"Amaral","year":"2020","journal-title":"Eur J Cancer"},{"key":"dcs200001r40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1200\/PO.19.00206","article-title":"Model combining tumor molecular and clinicopathologic risk factors predicts sentinel lymph node metastasis in primary cutaneous melanoma.","volume":"4","author":"Bellomo","year":"2020","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"dcs200001r41","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1158\/1078-0432.CCR-11-2202","article-title":"Development and use of integral assays in clinical trials.","volume":"18","author":"Schilsky","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"dcs200001r42","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-11-2203","article-title":"Bridging the gap: moving predictive and prognostic assays from research to clinical use.","volume":"18","author":"Williams","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"20","key":"dcs200001r43","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1158\/0008-5472.CAN-18-0747","article-title":"Spatially resolved transcriptomics enables dissection of genetic heterogeneity in stage III cutaneous malignant melanoma.","volume":"78","author":"Thrane","year":"2018","journal-title":"Cancer Res"},{"issue":"2","key":"dcs200001r44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.18632\/oncotarget.v11i2","article-title":"Circulating tumor DNA analysis in the era of precision oncology.","volume":"11","author":"Said","year":"2020","journal-title":"Oncotarget"},{"key":"dcs200001r45","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1007\/s11606-011-1899-y","article-title":"Chapter 12: systematic review of prognostic tests.","volume":"27","author":"Rector","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"4","key":"dcs200001r46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"Reporting recommendations for tumour marker prognostic studies (REMARK).","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"key":"dcs200001r47","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests.","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"dcs200001r48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1748-720X.2012.00678.x","article-title":"Effect of financial relationships on the behaviors of health care professionals: a review of the evidence.","volume":"40","author":"Robertson","year":"2012","journal-title":"J Law Med Ethics"},{"issue":"6","key":"dcs200001r49","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamaoncol.2018.6196","article-title":"Association between reimbursement incentives and physician practice in oncology: a systematic review.","volume":"5","author":"Mitchell","year":"2019","journal-title":"JAMA Oncol"},{"key":"dcs200001r20","volume-title":"Invasive Melanoma, Histopathology Reporting Guide","author":"Scolyer","year":"2019","edition":"2nd Edition"},{"key":"dcs200001r2","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): cutaneous melanoma. Version 1.2020. Accessed December 19, 2019. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf"},{"key":"dcs200001r3","unstructured":"Centers for Medicare & Medicaid Services. Advanced diagnostic laboratory tests under the Medicare CLFS. Accessed June 26, 2020. https:\/\/www.cms.gov\/files\/document\/advanced-diagnostic-laboratory-tests-under-medicare-clfs.pdf"},{"key":"dcs200001r4","unstructured":"Castle Biosciences announces Medicare coverage for the DecisionDx-Melanoma test in cutaneous melanoma. News release. Castle Biosciences. Accessed October 18, 2018. https:\/\/ir.castlebiosciences.com\/news-releases\/news-release-details\/castle-biosciences-announces-medicare-coverage-decisiondx"},{"key":"dcs200001r5","unstructured":"National Cancer Institute. Cancer Stat Facts: melanoma of the skin. Accessed December 11, 2019. https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html"},{"key":"dcs200001r39","unstructured":"SkylineDx launches melanoma test in United States to support cancer care. News release. SkylineDx. Accessed April 22, 2020. https:\/\/www.skylinedx.com\/news\/skylinedx-launches-melanoma-test-in-united-states-to-support-cancer-care"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2768743\/jamadermatology_grossman_2020_cs_200001_1599598384.81117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T22:06:46Z","timestamp":1667599606000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2768743"}},"subtitle":["Identifying the Knowledge Gaps and Assessing the Clinical Benefit"],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.1729","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738400663.793579642","asserted-by":"object"}]},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}